100% Quality Guarantee
PhD-Level Technical Support
Human anti- Aβ42 anbibody (anti-Amyloid Beta 42 antibody )ELISA Kit
Key Features

Human anti- Abeta42 anbibody (anti-Amyloid Beta 42 antibody) ELISA Kit (AEFI00117)

SKU AEFI00117
Product Type ELISA Kit
Size 96 Assays
Sensitivity 0.188ng/ml
Range 0.313-20ng/ml
ELISA Type Indirect
Reactivity Human
€649

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human anti- Abeta42 anbibody (anti-Amyloid Beta 42 antibody) ELISA Kit

The Human Anti-Aβ42 Antibody ELISA Kit is specifically designed for the precise and reliable detection of anti-amyloid beta-42 antibodies in human samples such as serum, plasma, and cell culture supernatants. This kit offers high sensitivity and specificity, ensuring accurate and reproducible results for a variety of research applications.Anti-amyloid beta-42 antibodies play a critical role in targeting and clearing amyloid plaques in the brain, which are a hallmark of Alzheimer's disease. By measuring levels of these antibodies, researchers can gain valuable insights into the body's immune response to amyloid beta accumulation and potentially identify new therapeutic targets for neurodegenerative disorders.

With its advanced technology and ease of use, the Human Anti-Aβ42 Antibody ELISA Kit is an indispensable tool for studying Alzheimer's disease and other related conditions, ultimately leading to a better understanding of disease mechanisms and the development of targeted treatments.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose